October 2013

Testicular Cancer: A Good News/Bad News Story

First, the good news: The survival rate for testicular cancer is 95 percent at 10 years, due to the invention of cisplatin-based chemotherapy in the 1970s. Despite this success, however, survivors have an increasing risk of second malignancies -- and the risk remains elevated for 35 years.

10/9/2013 | 0 comments

About the Blog

The goal of this blog is to bring more medical research stories to light and provide our readers with timely and engaging coverage of scientific and medical developments here in Rochester and beyond.

Follow @URMCResearch

Though health advice offered here is provided by experts, there is no substitute for the personal care your own provider can offer. If you have medical questions or concerns, please contact your physician.


Blog posts